欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/2644/001
药品名称Ganirelix SUN 0.25 mg/0.5 ml solution for injection
活性成分
    • ganirelix acetate 0.5 mg/ml
剂型Solution for injection
上市许可持有人Sun Pharmaceutical Industries Europe B.V. Polarisavenue 87, 2132 JH Hoofddorp The Netherlands
参考成员国 - 产品名称Netherlands (NL)
Ganirelix Sun
互认成员国 - 产品名称
    • Germany (DE)
      Ganirelix SUN 0,25 mg/0,5 ml Injektionslösung
    • Denmark (DK)
      Ganirelix "SUN"
    • United Kingdom (Northern Ireland) (XI)
    • Austria (AT)
    • France (FR)
    • Spain (ES)
    • Italy (IT)
    • Sweden (SE)
      48033
    • Norway (NO)
      Ganirelix SUN
    • Finland (FI)
    • Portugal (PT)
    • Slovakia (SK)
    • Czechia (CZ)
      Fyremadel 0,25 mg/0,5 ml injekční roztok v předplněné injekční stříkačce
    • Belgium (BE)
    • Greece (GR)
    • Poland (PL)
      Fyremadel
许可日期2013/04/24
最近更新日期2022/06/28
药物ATC编码
    • H01CC01 ganirelix
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase